SWISS RE LTD |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Jul. 08 | Swiss Re Unit to Fully Redeem $631 Million of Notes | MT |
| Jul. 05 | SWISS REINSURANCE COMPANY : JP Morgan gives a Buy rating | ZD |
Financials (USD)
| Sales 2024 * | 48.46B | Sales 2025 * | 50.46B | Capitalization | 35.93B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.92B | Net income 2025 * | 4.27B | EV / Sales 2024 * | 0.86 x |
| Net Debt 2024 * | 5.67B | Net Debt 2025 * | 5.62B | EV / Sales 2025 * | 0.82 x |
| P/E ratio 2024 * |
9.34
x | P/E ratio 2025 * |
8.52
x | Employees | - |
| Yield 2024 * |
5.87% | Yield 2025 * |
6.31% | Free-Float | 91.32% |
More Fundamentals
* Assessed data
More news
Latest transcript on Swiss Re Ltd
More recommendations
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Andreas Berger
CEO | Chief Executive Officer | 57 | 19-02-28 |
John Dacey
DFI | Director of Finance/CFO | 64 | 12-09-30 |
Velina Peneva
CIO | Chief Investment Officer | - | 16-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Larry Zimpleman
BRD | Director/Board Member | 72 | 18-04-19 |
| Director/Board Member | 68 | 17-04-20 | |
| Chairman | 63 | 17-04-20 |
Swiss Re Ltd is one of the world's leading reinsurance groups. Earned premiums break down by activity as follows:
- non-life reinsurance (51.6%): primarily damage, civil liability, automobile, accident, credit and guarantee, and other types of reinsurance;
- life and health reinsurance (34.7%; No. 1 worldwide): primarily life (69.2% of earned premiums) and health (30.8%);
- financial services (12.6%): asset management, investment capital, financial consulting, sales of structured products, etc.;
- others (1.1%).
Sector
Reinsurance
Calendar
2024-08-21
- Q2 2024 Earnings Call
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +33.89% | 8.66B | |
| +11.22% | 6.41B | |
| -2.12% | 4.96B | |
| +9.60% | 4.69B | |
| +11.19% | 846M | |
| +16.92% | 645M | |
| +24.29% | 554M | |
| +90.98% | 378M | |
| +15.74% | 171M |
